Nurix Therapeutics Announces Regulatory Clearance to Initiate Phase 1 Clinical Trial of NX-5948 and Presents New Preclinical Data at the American Society of Hematology Annual Meeting

NEXT STORY
NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
PREV STORY
Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Novavax, Inc. with Lead Plaintiff Deadline Approaching
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Darolutamide plus androgen deprivation therapy significantly increased overall survival in men with non-metastatic castration-resistant prostate cancer

author_avatar
NASDAQ Market News

Novartis Cosentyx® shows superior improvements in psoriasis patients’ quality of life versus Janssen’s IL-23 Stelara®*

author_avatar
NASDAQ Market News

Innate Pharma presented translational data from the Phase II of monalizumab and cetuximab at SITC

SITC 2018: FURTHER ANALYSES OF THE PHASE II STUDY OF THE COMBINATION OF MONALIZUMAB ...

author_avatar
NASDAQ Market News